Analys

NANEXA: Financing secured into 2026 to drive NEX-22 development

Analys, Research

Johan Widmark | 2025-01-27 08:00  READ FULL REPORT HERE IN PDF With the directed issue of units amounting to SEK 35m, supplemented by SEK...

Read More

GRANGEX: PEA confirmns robust economics for Sydvaranger – mapping the road to financial close in H2’25

Analys, Research

With the release of a Preliminary Economic Assessment (PEA) for the restart of the Sydvaranger mine, GRANGEX now has more clarity on the...

Read More

PROLIGHT: SpinChip deal highlights the strategic importance and valuation potential of Prolight’s solution

Analys, Research

The recent acquisition of Norwegian point-of-care diagnostics platform SpinChip by bioMérieux for EUR 138 million underscores the growing...

Read More

PROLIGHT: Commercial prototype marks an important milestone towards upcoming studies

Analys, Research

The arrival of the first commercial prototype instruments for Prolight’s Psyros Point of Care (POC) system marks an important development...

Read More

PROLIGHT: Advancing with strengthened financials towards clinical performance study in 2025

Analys, Research

Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation study, including fresh blood samples from...

Read More

NANEXA: Progress for rival at Novo illustrates the significant value potential in Nanexa

Analys, Research

NEX-22 is progressing as expected, with the last patient in Phase I treated, results anticipated later in November, and Phase IIb scheduled...

Read More

CRUNCHFISH: Q3 report webinar

Analys, Research

On Friday Nov 1st, 2024 Crunchfish hosted a webinar in connection with the Q3’24 report, where CEO Joachim Samulesson was interviewed...

Read More

CRUNCHFISH: Rights issue to stay the course on extended timeline

Analys, Research

As discussed in our previous update, Crunchfish has now settled on a path forward for the company’s financing. On Friday after the...

Read More

GRANGEX: Emerging as Europe’s top DR concentrate developer

Analys, Research

With the dust settling after the acquisition of Sydvaranger and the updated DFS for Dannemora in Q2’24, the next steps for GRANGEX are...

Read More

MOTION DISPLAY: Strong gross margin driving another profitable quarter  

Analys, Research

MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in Q2’23. The gross margin increased by 6ppt...

Read More

For new research on growth stocks, sign up to our newsletter